Welcome to

He Ako Hiringa

Our mission is to contribute to creating equitable access to funded medicines, by providing education and updates to primary care clinicians.

Our resources are free to access. Log in and record your professional development using our CAPTURE function (at the end of each article).

He Ako Hiringa is intended for use by primary care health professionals - it is not a consumer information or education service. Consumers should seek advice from a health professional or visit www.healthnavigator.co.nz.

Our latest content

A consultant general practitioner from Botany Junction Medical is the winner of a $2000 travel voucher after logging into the new He Ako Hiringa EPiC dashboard. Click here to read more. 

Contributor
He Ako Hiringa
3 August 2022
1 minute to Read

EPiC is a free, data-driven tool that enables users to explore individual, practice and national prescribing behaviours. Insights from EPiC data can help users to consider their practice and inform targeted interventions or quality improvement initiatives.

Contributor
He Ako Hiringa
1 August 2022

To help you get the most out of the EPiC prescribing dashboard, we've formed the EPiC data club. Both prescribers and non-prescribers can join the free data club meetings, where we'll take you on a guided tour to fully explore the dashboard data and reflection activities. You can choose to sign up as an individual or as a practice team. Our next data club is Wednesday 17 August, 6:00pm-7:00pm.

Contributor
He Ako Hiringa
26 July 2022
5 minutes to Read

The antihypertensive medicine Accuretic (quinapril in combination with hydrochlorothiazide), is being withdrawn. Prescribers are advised to change all patients taking Accuretic to alternative medicine(s) when their next monthly prescription is due. Read our article for dose equivalence tables and information on switching, monitoring, co-payments and consultation fees.
 

Contributor
Dr Noni Richards
4 July 2022

This guide highlights the different features in EPiC, helping you to navigate through the dashboard. Our case study provides an example of how EPiC can be used to carry out quality improvement activities. 

View online or click the print-ready version.

Contributor
Dr Noni Richards
20 July 2022

With recent funding changes to adalimumab, prescribers are being urged to change patients from Humira (the reference biological) to Amgevita (a biosimilar). We’ve collated this list of questions and answers, with links to other useful resources, to help inform your conversations with colleagues and patients.

Contributor
He Ako Hiringa
16 June 2022

Thirsty for knowledge?

Subscribe to our newsletter to remain up to date with all our content and new features.